abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof:n n n Formula In n n n n n n n Wheren n n R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and X are as defined herein.n n n The compounds are useful for the treatment and / or prevention of diseases related to the modulation of CB1 receptors. |